1. Feb 28, 2017

    A multidisciplinary approach to genitourinary cancers

    Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer.

  2. Apr 9, 2015

    Surgical treatment options for people with prostate cancer

    Igor Frank, M.D., discusses surgical treatment options for people with prostate cancer.

  3. Nov 21, 2014

    Peyronie's disease therapies

    Urologist Landon W. Trost, M.D., who specializes in andrology and male infertility at Mayo Clinic in Rochester, Minnesota, discusses treatment options for patients with Peyronie's disease — the development of fibrous scar tissue inside the penis that causes curved, painful erections.

  4. Nov 20, 2014

    Therapies for nonpsychogenic erectile dysfunction

    Landon W. Trost, M.D., assistant professor of urology and current head of Andrology and Male Infertility, Mayo Clinic, Rochester, Minnesota, discusses therapies for nonpsychogenic erectile dysfunction.

  5. Nov 5, 2014

    Bladder cancer treatment options

    R. Jeffrey Karnes, M.D., consultant and associate professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into subcategories, and the treatments dramatically differ. Invasive treatments can include an ileal neobladder created from the patient's small intestine, which can provide the best quality of life.

  6. Oct 8, 2014

    Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

    Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

  7. Oct 7, 2014

    Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows

    A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups.

  8. Oct 1, 2014

    Less-radical procedures offer similar cancer control compared with surgery for kidney cancer patients

    Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.

  9. Jun 30, 2014

    Erectile dysfunction: Harbinger of heart disease?

    Charanjit S. Rihal, M.D., and Stephen L. Kopecky, M.D., discuss erectile dysfunction and its impact on cardiovascular prognosis and diagnosis.

  10. Jun 27, 2014

    PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study

    The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer.

  11. Jun 26, 2014

    Ultrafiltration for Heart Failure (HF) with cardiorenal syndrome: CARRESSing the kidneys or rubbing them the wrong way?

    Eddie L. Greene, M.D., Horng H. Chen, M.D., and Margaret M. Redfield, M.D., gathered to discuss the design, results and implications of the cardiorenal rescue study in acute decompensated heart failure (CARRESS).

  12. May 22, 2014

    Choline C-11: Pulling back the curtain on prostate cancer

    Mayo Clinic has integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to prostate cancer patients.

  13. Mar 11, 2014

    Robotic neobladder procedure

    Mayo Clinic's Erik P. Castle, M.D., and Mitchell R. Humphreys, M.D., explain and demonstrate the neobladder procedure.

  14. Mar 3, 2014

    Prostate cancer developments — Mayo Clinic Proceedings

    Manish Kohli, M.D., of Mayo Clinic, discusses his January 2010 Mayo Clinic Proceedings article on new developments in the medical management of prostate cancer.

  15. Mar 3, 2014

    Predictors of ADT response in advanced prostate cancer

    Manish Kohli, M.D., associate professor of medical oncology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the March 2012 issue of Mayo Clinic Proceedings.

  16. Mar 3, 2014

    New developments in the medical management of prostate cancer

    Manish Kohli, M.D., of Mayo Clinic, discusses his January 2010 Mayo Clinic Proceedings article on new developments in the medical management of prostate cancer.

  17. Mar 3, 2014

    Mayo Clinic study suggests routine prostate size evaluation not as effective in cancer screening

    If a man's PSA is quickly rising, he likely deserves a prostate biopsy to determine if he has prostate cancer. Assessment of change in prostate size should not influence the decision to biopsy. Dr. Rodney Breau discusses the study and its findings in this video.

  18. Feb 28, 2014

    Biopsy-based predictors of prostate cancer mortality: The Mayo Model

    Matthew K. Tollefson, M.D., provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting.

  19. Feb 28, 2014

    16-year longitudinal changes in serum prostate-specific antigen (PSA) levels

    Jennifer St. Sauver, Ph.D., associate professor of epidemiology in the Department of Health Sciences Research at Mayo Clinic in Rochester, Minnesota, discusses her article appearing in the January 2012 issue of Mayo Clinic Proceedings.